Tenax Therapeutics Inc. | Key People and Executives
Anthony A. DiTonno
Chief Executive Officer & Director
Ronald R. Blanck
Chairman
James P. Mitchum
Independent Director
Gerald T. Proehl
Independent Director
Chris A. Rallis
Independent Director
Gregory Pepin
Independent Director
Anthony A. DiTonno
Chief Executive Officer & Director
Doug Randall
Executive VP-Commercial & Business Operations
Michael B. Jebsen
Chief Financial Officer & Treasurer
Nancy J. Hecox
Secretary, EVP-Legal Affairs & General Counsel
Douglas Hay
Executive Vice President-Regulatory Affairs
Ronald R. Blanck
Chairman
James P. Mitchum
Independent Director
Gerald T. Proehl
Independent Director
Chris A. Rallis
Independent Director
Gregory Pepin
Independent Director
| Address |
ONE Copley Parkway
Morrisville North Carolina 27560
United States
|
|
Employees
|
- |
| Website |
http://www.tenaxthera.com |
| Updated |
07/08/2019 |
| Tenax Therapeutics, Inc. is a pharmaceutical company, which focuses on identifying, developing, and commercializing novel therapeutic products for the critical care market. Its product candidate includes Levosimendan, a calcium sensitizer activator for intravenous use in hospitalized patients with acutely decompensated heart failure. The company was founded on May 26, 1967 and is headquartered in Morrisville, NC. |
